Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Climb Bio (CLYM)
NASDAQ:CLYM
Climb Bio (CLYM) Ownership Overview
8.53% Insiders
3.39% Mutual Funds
63.16% Other Institutional Investors
4.42% ETFs
20.50% Public Companies and
Individual Investors
The ownership structure of Climb Bio (CLYM) stock is a mix of institutional, retail, and individual investors. Approximately 70.97% of the company’s stock is owned by Institutional Investors, 8.53% is owned by Insiders, and 20.50% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jul 23, 2024 | Valerie Morisset Evp, R&d And Cso | xxxxxxxxxxxxx | $988495 |
| Jul 19, 2024 | Valerie Morisset Evp, R&d And Cso | xxxxxxxxxxxxx | $289492 |
| Jul 17, 2024 | Valerie Morisset Evp, R&d And Cso | xxxxxxxxxxxxx | $356500 |
| Jul 16, 2024 | Valerie Morisset Evp, R&d And Cso | xxxxxxxxxxxxx | $650563 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 31,419,267 | Institution | 46.69% | 47,757,286 | |
| 5,417,638 | Insider | 8.05% | 8,234,810 | |
| 1,479,275 | Institution | 2.20% | 2,248,498 | |
| 1,440,822 | Institution | 2.14% | 2,190,049 | |
| 1,303,768 | Institution | 1.94% | 1,981,727 | |
| 612,387 | Institution | 0.91% | 930,828 | |
| 331,830 | Institution | 0.49% | 504,382 | |
| 259,499 | Institution | 0.39% | 394,438 | |
| 178,100 | Insider | 0.26% | 270,712 | |
| 157,734 | Institution | 0.23% | 239,756 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,303,768 | Institution | 1.94% | 1,981,727 | |
| 331,830 | Institution | 0.49% | 504,382 | |
| 259,499 | Institution | 0.39% | 394,438 | |
| 157,734 | Institution | 0.23% | 239,756 | |
| 70,093 | Institution | 0.10% | 106,541 | |
| 39,034 | Institution | 0.06% | 59,332 | |
| 25,309 | Institution | 0.04% | 38,470 | |
| 19,824 | Institution | 0.03% | 30,132 | |
| 15,439 | Institution | 0.02% | 23,467 | |
| 12,359 | Institution | 0.02% | 18,786 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 876,321 | Institution | 1.30% | 1,577,378 | |
| 753,701 | Institution | 1.12% | 1,145,626 | |
| 404,120 | Institution | 0.60% | 727,416 | |
| 320,690 | Institution | 0.48% | 487,449 | |
| 251,655 | Institution | 0.37% | 382,516 | |
| 137,091 | Institution | 0.20% | 246,764 | |
| 67,504 | Institution | 0.10% | 102,606 | |
| 33,101 | Institution | 0.05% | 52,631 | |
| 19,484 | Institution | 0.03% | 35,071 | |
| 16,778 | Institution | 0.02% | 26,677 |
FAQ
Who Owns Climb Bio (CLYM)?
According to the latest TipRanks data, approximately 63.16% of the company's stock is held by institutional investors, 8.53% is held by insiders, and 20.50% is held by retail investors.
What percentage of Climb Bio (CLYM) stock is held by institutional investors?
According to the latest TipRanks data, approximately 63.16% of Climb Bio (CLYM) stock is held by institutional investors.
What percentage of Climb Bio (CLYM) stock is held by retail investors?
According to the latest TipRanks data, approximately 20.50% of Climb Bio (CLYM) stock is held by retail investors.
Who owns the most shares of Climb Bio (CLYM)?
Peter Kolchinsky owns the most shares of Climb Bio (CLYM).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.